
Number of publications published per year by Lencioni, Riccardo. (Source : PubMed)

Distribution of publications types for Lencioni, Riccardo. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Modified RECIST (mRECIST) assessment for hepatocellular carcinoma.
Semin. Liver Dis.
2010;30;1
Hepatocellular carcinoma: new options for image-guided ablation.
J Hepatobiliary Pancreat Surg
2009
Ethanol ablation of hepatocellular carcinoma Up to 5.0 cm by using a multipronged injection needle with high-dose strategy.
Radiology
2009;253;2

Guidelines for imaging focal lesions in liver cirrhosis.
Expert review of gastroenterology & hepatology
2008;2;5

Doxorubicin-eluting bead-enhanced radiofrequency ablation of hepatocellular carcinoma: a pilot clinical study.
J. Hepatol.
2008;49;2


Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study).
Lancet Oncol.
2008;9;7


Design and endpoints of clinical trials in hepatocellular carcinoma.
J. Natl. Cancer Inst.
2008;100;10

Contrast-enhanced ultrasound in the diagnosis of hepatocellular carcinoma.
J. Hepatol.
2008;48;5

What is the long-term survival benefit of radiofrequency ablation in patients with colorectal liver metastases?
Nature clinical practice. Gastroenterology & hepatology
2008;5;5

Treatment before liver transplantation for HCC.
Annals of surgical oncology
2008;15;4
[ See timeline ] [ See all publications ]
means that Lencioni, Riccardo has 37 papers cited a least 37 times - methodology
Division of Diagnostic and Interventional Radiology, Department of Oncology, Transplants and Advanced Technologies in Medicine, University of Pisa, Via Roma 67, IT-56126, Pisa, Italy.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.